Spark Biomedical published a first-in-human study, showing its tAN platform can enhance platelet function. Spark's device delivers non-invasive electrical stimulation at the ear to engage neural pathways involved in clot formation. The study offers the first clinical evidence that ear-based nerve stimulation can strengthen the body's natural clotting response. The findings support Spark's drug-free approach to stopping severe bleeding, with potential applications in surgery, trauma, and military settings.